Warning:
This site is being maintained for historical purposes, but has had no new entries
since October 1998. To find more recent articles, please visit the following:
-
MMWR
at http://www.cdc.gov/mmwr/mmwrsrch.htm
-
CDC Web Search
at http://www.cdc.gov/search.htm
Prevention Guidelines
Topic: AIDS
(Please note that the documents listed below are sorted by date.)
Management of Possible Sexual, Injecting-Drug-Use, or Other Nonoccupational Exposure to HIV, Including Considerations Related to Antiretroviral Therapy Public Health Service Statement; 1998:09:25
HIV Prevention Through Early Detection and Treatment of Other Sexually Transmitted Diseases -- United States Recommendations of the Advisory Committee for HIV and STD Prevention; 1998:07:31
Public Health Service Guidelines for the Management of Health-Care Worker Exposures to HIV and Recommendations for Postexposure Prophylaxis; 1998:05:15
Guidelines for the Use of Antiretroviral Agents in HIV-Infected Adults and Adolescents; 1998:04:24
Report of the NIH Panel to Define Principles of Therapy of HIV Infection; 1998:04:24
Update: HIV Counseling and Testing Using Rapid Tests -- United States, 1995; 1998:03:27
Administration of Zidovudine During Late Pregnancy and Delivery to Prevent Perinatal HIV Transmission -- Thailand, 1996-1998; 1998:03:06
HIV/AIDS Among American Indians and Alaskan Natives -- United States, 1981-1997; 1998:03:06
1998 Guidelines for Treatment of Sexually Transmitted Diseases; 1998:01:23
Anergy Skin Testing and Preventive Therapy for HIV-Infected Persons: Revised Recommendations; 1997:09:05
1997 USPHS/IDSA Guidelines for the Prevention of Opportunistic Infections in Persons Infected with Human Immunodeficiency Virus; 1997:06:27
Update: Syringe-Exchange Programs -- United States, 1996; 1997:06:20
Notice to Readers Publication of HIV-Prevention Bulletin for Health-Care Providers Regarding Advice to Persons Who Inject Illicit Drugs; 1997:06:06
Case Definitions for Infectious Conditions Under Public Health Surveillance; 1997:05:02
1997 Revised Guidelines for Performing CD4+ T-Cell Determinations in Persons Infected with Human Immunodeficiency Virus (HIV); 1997:01:10
Coccidioidomycosis -- Arizona, 1990-1995; 1996:12:13
Health Information for International Travel 1996-97; 1996:12:01
Notice to Readers Update: Provisional Public Health Service Recommendations For Chemoprophylaxis After Occupational Exposure to HIV; 1996:06:07
Community-Level Prevention of Human Immunodeficiency Virus Infection Among High-Risk Populations: The AIDS Community Demonstration Projects; 1996:05:10
Guidelines for Isolation Precautions in Hospitals Hospital Infection Control Advisory Committee; 1996:01:01
Case-Control Study of HIV Seroconversion in Health-Care Workers After Percutaneous Exposure to HIV-Infected Blood -- France, United Kingdom, and United States, January 1988-August 1994; 1995:12:22
Essential Components of a Tuberculosis Prevention and Control Program Recommendations of the Advisory Council for the Elimination of Tuberculosis; 1995:09:08
Screening for Tuberculosis and Tuberculosis Infection in High-Risk Populations Recommendations of the Advisory Council for the Elimination of Tuberculosis; 1995:09:08
USPHS/IDSA Guidelines for the Prevention of Opportunistic Infections in Persons Infected with Human Immunodeficiency Virus: A Summary; 1995:07:14
U.S. Public Health Service Recommendations for Human Immunodeficiency Virus Counseling and Voluntary Testing for Pregnant Women; 1995:07:07
Assessing the Public Health Threat Associated with Waterborne Cryptosporidiosis: Report of a Workshop; 1995:06:16
1995 Revised Guidelines for Prophylaxis Against Pneumocystis carinii Pneumonia for Children Infected with or Perinatally Exposed to Human Immunodeficiency Virus; 1995:04:28
Guidelines for Health Education and Risk Reduction Activities; 1995:04:01
1994 Revised Classification System for Human Immunodeficiency Virus Infection in Children Less Than 13 Years of Age; 1994:09:30
Official Authorized Addenda: Human Immunodeficiency Virus Infection Codes and Official Guidelines for Coding and Reporting ICD-9-CM; 1994:09:30
Recommendations of the U.S. Public Health Service Task Force on the Use of Zidovudine to Reduce Perinatal Transmission of Human Immunodeficiency Virus; 1994:08:05
Guidelines for Preventing Transmission of Human Immunodeficiency Virus Through Transplantation of Human Tissue and Organs; 1994:05:20
Zidovudine for the Prevention of HIV Transmission from Mother to Infant; 1994:04:29
Addressing Emerging Infectious Disease Threats: A Prevention Strategy for the United States Executive Summary; 1994:04:15
Update: Barrier Protection Against HIV Infection and Other Sexually Transmitted Diseases; 1993:08:06
Acquired Immunodeficiency Syndrome -- United States, 1992; 1993:07:23
Recommendations for Counseling Persons Infected with Human T-Lymphotrophic Virus, Types I and II *; 1993:06:25
Recommendations on Prophylaxis and Therapy for Disseminated Mycobacterium avium Complex for Adults and Adolescents Infected with Human Immunodeficiency Virus; 1993:06:25
Investigations of Persons Treated by HIV-Infected Health-Care Workers -- United States; 1993:05:07
Recommendations of the Advisory Committee on Immunization Practices (ACIP): Use of Vaccines and Immune Globulins in Persons with Altered Immunocompetence; 1993:04:09
Recommendations for HIV Testing Services for Inpatients and Outpatients in Acute-Care Hospital Settings; 1993:01:15
Technical Guidance on HIV Counseling; 1993:01:15
Dental Infection Control File, 1993 and Recommended Infection- Control Practices for Dentistry, 1993; 1993:01:01
1993 Revised Classification System for HIV Infection and Expanded Surveillance Case Definition for AIDS Among Adolescents and Adults; 1992:12:18
CDC/ATSDR Protocol for Handling Occupational Exposures to Human Immunodeficiency Virus (HIV); 1992:11:10
Patient Exposures to HIV During Nuclear Medicine Procedures; 1992:08:07
Testing for Antibodies to Human Immunodeficiency Virus Type 2 in the United States; 1992:07:17
Management of Persons Exposed to Multidrug-Resistant Tuberculosis; 1992:06:19
National Action Plan to Combat Multidrug-Resistant Tuberculosis; 1992:06:19
Guidelines for the Performance of CD4+ T-Cell Determinations in Persons with Human Immunodeficiency Virus Infection; 1992:05:08
Recommendations for Prophylaxis Against Pneumocystis carinii Pneumonia for Adults and Adolescents Infected with Human Immunodeficiency Virus; 1992:04:03
Interpretive Criteria Used to Report Western Blot Results for HIV-1-Antibody Testing -- United States; 1991:10:11
Recommendations for Preventing Transmission of Human Immunodeficiency Virus and Hepatitis B Virus to Patients During Exposure-Prone Invasive Procedures; 1991:07:12
Epidemiologic Notes and Reports Update: Transmission of HIV Infection During Invasive Dental Procedures --- Florida; 1991:06:14
Current Trends Preliminary Analysis: HIV Serosurvey of Orthopedic Surgeons, 1991; 1991:05:17
Purified Protein Derivative (PPD)-Tuberculin Anergy and HIV Infection: Guidelines For Anergy Testing And Management Of Anergic Persons At Risk Of Tuberculosis; 1991:04:26
Guidelines for Prophylaxis Against Pneumocystis carinii Pneumonia for Children Infected with Human Immunodeficiency Virus; 1991:03:15
Guidelines for Prophylaxis Against Pneumocystis carinii Pneumonia for Children Infected with Human Immunodeficiency Virus; 1991:03:15
Epidemiologic Notes and Reports Update: Transmission of HIV Infection during an Invasive Dental Procedure -- Florida; 1991:01:18
Epidemiologic Notes and Reports Risk for Cervical Disease in HIV-Infected Women -- New York City; 1990:11:30
Current Trends Surveillance for HIV-2 Infection in Blood Donors -- United States, 1987-1989; 1990:11:23
Epidemiologic Notes and Reports Nosocomial Transmission of Multidrug-Resistant Tuberculosis to Health-Care Workers and HIV-Infected Patients in an Urban Hospital -- Florida; 1990:10:12
International Notes Tuberculin Reactions in Apparently Healthy HIV-Seropositive and HIV-Seronegative Women -- Uganda; 1990:09:21
Possible Transmission of Human Immunodeficiency Virus to a Patient during an Invasive Dental Procedure; 1990:07:27
Epidemiologic Notes and Reports HIV-1 Infection and Artificial Insemination with Processed Semen; 1990:04:20
Public Health Service statement on management of occupational exposure to human immunodeficiency virus, including considerations regarding zidovudine postexposure use; 1990:01:26
HIV Infection Reporting -- United States; 1989:07:21
Interpretation and Use of the Western Blot Assay for Serodiagnosis of Human Immunodeficiency Virus Type 1 Infections; 1989:07:21
Current Trends Update: Heterosexual Transmission of Acquired Immunodeficiency Syndrome and Human Immunodeficiency Virus Infection -- United States; 1989:06:23
Guidelines for Prevention of Transmission of Human Immunodeficiency Virus and Hepatitis B Virus to Health-Care and Public-Safety Workers; 1989:06:23
Current Trends Problems Created by Heat-Inactivation of Serum Specimens Before HIV-1 Antibody Testing; 1989:06:16
Guidelines for Prophylaxis Against Pneumocystis carinii Pneumonia for Persons Infected with Human Immunodeficiency Virus; 1989:06:16
Perspectives in Disease Prevention and Health Promotion Guidelines to Prevent Simian Immunodeficiency Virus Infection in Laboratory Workers and Animal Handlers; 1988:11:18
Epidemiologic Notes and Reports Transmission of HIV Through Bone Transplantation: Case Report and Public Health Recommendations; 1988:10:07
Human Immunodeficiency Virus Infection/Acquired Immunodeficiency Syndrome Revised Chapter X from "Guidelines for STD Control Program Operations"; 1988:09:01
Current Trends Partner Notification for Preventing Human Immunodeficiency Virus (HIV) Infection -- Colorado, Idaho, South Carolina, Virginia; 1988:07:01
Perspectives in Disease Prevention and Health Promotion Update: Universal Precautions for Prevention of Transmission of Human Immunodeficiency Virus, Hepatitis B Virus, and Other Bloodborne Pathogens ; 1988:06:24
Update: Acquired Immunodeficiency Syndrome and Human Immunodefiency Virus Infection Among Health-Care Workers; 1988:04:22
Agent Summary Statement for Human Immunodeficiency Viruses (HIVs) Including HTLV-III, LAV, HIV-1, and HIV-2*; 1988:04:01
Occupationally Acquired Human Immunodeficiency Virus Infections in Laboratories Producing Virus Concentrates in Large Quantities: Conclusions and Recommendations of an Expert Team Convened by the Dire; 1988:04:01
Recommendations of the Immunization Practices Advisory Committee (ACIP) Immunization of Children Infected With Human Immunodeficiency Virus --; 1988:04:01
Perspectives in Disease Prevention and Health Promotion Semen Banking, Organ and Tissue Transplantation, and HIV Antibody Testing; 1988:02:05
Guidelines for Effective School Health Education To Prevent the Spread of AIDS; 1988:01:29
Guidelines for the Prevention and Control of Congenital Syphilis; 1988:01:15
Current Trends Update: Serologic Testing for Antibody to Human Immunodeficiency Virus; 1988:01:08
Notice to Readers Revision of HIV Classification Codes; 1988:01:01
Guidelines for AIDS Prevention Program Operations; 1987:10:01
Recommendations for Prevention of HIV Transmission in Health-Care Settings; 1987:08:21
Perspectives in Disease Prevention and Health Promotion Public Health Service Guidelines for Counseling and Antibody Testing to Prevent HIV Infection and AIDS; 1987:08:14
Epidemiologic Notes and Reports Human Immunodeficiency Virus Infection Transmitted From on Organ Donor Screened for HIV Antibody - North Carolina; 1987:05:29
Epidemiologic Notes and Reports Update: Human Immunodeficiency Virus Infections in Health-Care Workers Exposed to Blood of Infected Patients; 1987:05:22
Current Trends Classification System for Human Immunodeficiency Viru (HIV) Infection in Children Under 13 Years of Age; 1987:04:24
Recommendation of the Immunization Practices Advisory Committee Immunization of Children Infected with Human T-Lymphotropic Virus Type III/ Lymphadenopathy-Associated Virus; 1986:09:26
Tuberculosis and Acquired Immunodeficiency Syndrome -- Florida; 1986:09:19
Current Trends Human T-Lymphotropic Virus Type III/ Lymphadenopathy-Associated Virus: Agent Summary Statement; 1986:08:29
Diagnosis and Management of Mycobacterial Infection and Disease in Persons with Human T-Lymphotropic Virus Type III/ Lymphadenopathy-Associated Virus Infection; 1986:07:18
Current Trends Recommendations for Providing Dialysis Treatment to Patients Infected with Human T-Lymphotropic Virus Type III/Lymphadenopathy-Associated Virus; 1986:06:13
Current Trends Recommendations for Preventing Transmission of Infection with Human T-Lymphotropic Virus Type III/ Lymphadenopathy-Associated Virus during Invasive Procedures; 1986:04:11
Safety of Therapeutic Immune Globulin Preparations with Respect to Transmission of Human T-Lymphotropic Virus Type III/ Lymphadenopathy-Associated Virus Infection; 1986:04:11
Current Trends Additional Recommendations to Reduce Sexual and Drug Abuse-Related Transmission of Human T-Lymphotropic Virus Type III/ Lymphadenopathy-Associated Virus; 1986:03:14
Current Trends Recommendations for Assisting in the Prevention of Perinatal Transmission of Human T-Lymphotropic Virus Type III/Lymphadenopathy-Associated Virus and Acquired Immunodeficiency Syndrome; 1985:12:06
Current Trends Summary: Recommendations for Preventing Transmission of Infection with Human T-Lymphotropic Virus Type III/ Lymphadenopathy-Associated Virus in the Workplace; 1985:11:15
Recommendations for Preventing Transmission of Infection with Human T-Lymphotropic Virus Type III/ Lymphadenopathy-Associated Virus in the Workplace; 1985:11:15
Epidemiologic Notes and Reports Update: Evaluation of Human T-Lymphotropic Virus Type III/ Lymphadenopathy-Associated Virus Infection in Health-Care Personnel -- United States; 1985:09:27
Update: Revised Public Health Service Definition of Persons Who Should Refrain from Donating Blood and Plasma -- United States; 1985:09:06
Current Trends Education and Foster Care of Children Infected with Human T-Lymphotropic Virus Type III/ Lymphadenopathy-Associated Virus; 1985:08:30
Current Trends Recommendations for Preventing Possible Transmission of Human T-Lymphotropic Virus Type III/ Lymphadenopathy- Associated Virus from Tears; 1985:08:30
Epidemiologic Notes and Reports Testing Donors of Organs, Tissues, and Semen for Antibody to Human T-Lymphotropic Virus Type III/Lymphadenopathy-Associated Virus; 1985:05:24
Current Trends World Health Organization Workshop: Conclusions and Recommendations on Acquired Immunodeficiency Syndrome; 1985:05:17
Current Trends Update: Prospective Evaluation of Health-Care Workers Exposed via the Parenteral or Mucous-Membrane Route to Blood or Body Fluids from Patients with Acquired Immunodeficiency Syndrome -; 1985:02:22
Provisional Public Health Service Inter-Agency Recommendations for Screening Donated Blood and Plasma for Antibody to the Virus Causing Acquired Immunodeficiency Syndrome; 1985:01:11
Current Trends Hepatitis B Vaccine: Evidence Confirming Lack of AIDS Transmission; 1984:12:14
Update: Acquired Immunodeficiency Syndrome (AIDS) in Persons with Hemophilia; 1984:10:26
Prospective Evaluation of Health-Care Workers Exposed via Parenteral or Mucous-Membrane Routes to Blood and Body Fluids of Patients with Acquired Immunodeficiency Syndrome; 1984:04:06
Acquired Immunodeficiency Syndrome (AIDS): Precautions for Health-Care Workers and Allied Professionals; 1983:09:02
Epidemiologic Notes and Reports An Evaluation of the Acquired Immunodeficiency Syndrome (AIDS) Reported in Health-Care Personnel -- United States; 1983:07:15
Current Trends Prevention of Acquired Immune Deficiency Syndrome (AIDS): Report of Inter-Agency Recommendations; 1983:03:04
Current Trends Acquired Immune Deficiency Syndrome (AIDS): Precautions for Clinical and Laboratory Staffs; 1982:11:05
